{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:09:00Z","timestamp":1791295740547,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.4065\/81.2.159","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:27:47Z","timestamp":1232742467000},"page":"159-166","source":"Crossref","is-referenced-by-count":266,"title":["Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors"],"prefix":"10.4065","volume":"81","author":[{"given":"Alexandra P.","family":"Wolanskyj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Schwager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca F.","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/81.2.159_bib1","series-title":"World Health Organization Classification of Tumours: Tumours of the Haematopoietic and Lymphoid Tissues","first-page":"17","article-title":"WHO histological classification of chronic myeloproliferative diseases","author":"Vardiman","year":"2001"},{"key":"10.4065\/81.2.159_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I","article-title":"Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County study, 1976-1995","volume":"61","author":"Mesa","year":"1999","journal-title":"Am J Hematol"},{"key":"10.4065\/81.2.159_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1034\/j.1600-0609.2000.90236.x","article-title":"Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area","volume":"65","author":"Jensen","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.4065\/81.2.159_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1099-1069(199711)15:4<173::AID-HON610>3.0.CO;2-K","article-title":"Age and sex distributions of hematological malignancies in the U.K","volume":"15","author":"McNally","year":"1997","journal-title":"Hematol Oncol"},{"key":"10.4065\/81.2.159_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.4065\/81.2.159_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj.leu.2401270","article-title":"Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients","volume":"13","author":"Besses","year":"1999","journal-title":"Leukemia"},{"key":"10.4065\/81.2.159_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"key":"10.4065\/81.2.159_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1365-2141.2002.03688.x","article-title":"Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients","volume":"118","author":"Cervantes","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/81.2.159_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4065\/76.1.22","article-title":"A long-term retrospective study of young women with essential thrombocythemia","volume":"76","author":"Tefferi","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/81.2.159_bib10","first-page":"215","article-title":"Practice guidelines for the therapy of essential thrombocythemia: a statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation","volume":"89","author":"Barbui","year":"2004","journal-title":"Haematologica"},{"key":"10.4065\/81.2.159_bib11","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","article-title":"Life expectancy of patients with chronic nonleukemic myeloproliferative disorders","volume":"67","author":"Rozman","year":"1991","journal-title":"Cancer"},{"key":"10.4065\/81.2.159_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00277-004-0882-7","article-title":"Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman","volume":"83","author":"Passamonti","year":"2004","journal-title":"Ann Hematol"},{"key":"10.4065\/81.2.159_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0895-4356(89)90066-8","article-title":"The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy","volume":"42","author":"Landefeld","year":"1989","journal-title":"J Clin Epidemiol"},{"key":"10.4065\/81.2.159_bib14","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2002-07-2341","article-title":"Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia","volume":"101","author":"Reeder","year":"2003","journal-title":"Blood"},{"key":"10.4065\/81.2.159_bib15","first-page":"871","article-title":"FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia","volume":"89","author":"Tefferi","year":"2004","journal-title":"Haematologica"},{"key":"10.4065\/81.2.159_bib16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and myelodysplastic syndromes","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.4065\/81.2.159_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s002770050555","article-title":"Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia","volume":"78","author":"Bazzan","year":"1999","journal-title":"Ann Hematol"},{"key":"10.4065\/81.2.159_bib18","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"key":"10.4065\/81.2.159_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2001.00359.x","article-title":"Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count","volume":"66","author":"Jensen","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.4065\/81.2.159_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exphem.2005.01.015","article-title":"Leukocyteplatelet interaction in patients with essential thrombocythemia and polycythemia vera","volume":"33","author":"Falanga","year":"2005","journal-title":"Exp Hematol"},{"key":"10.4065\/81.2.159_bib21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4065\/81.2.159_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"10.4065\/81.2.159_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2141.1998.00529.x","article-title":"Should a platelet limit of 600 \u00d7 109\/l be used as a diagnostic criterion in essential thrombocythaemia? an analysis of the natural course including early stages","volume":"100","author":"Lengfelder","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/81.2.159_bib24","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3","article-title":"Thrombotic and hemorrhagic complications in essential thrombocythemia: a retrospective study of 103 patients","volume":"67","author":"Colombi","year":"1991","journal-title":"Cancer"},{"key":"10.4065\/81.2.159_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002770000244","article-title":"The predictive value of vascular risk factors and gender for the development of thrombotic complications in essential thrombocythemia","volume":"80","author":"Jantunen","year":"2001","journal-title":"Ann Hematol"},{"key":"10.4065\/81.2.159_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1992.03480090101035","article-title":"White blood cell count and cardiovascular disease: insights from the Framingham Study","volume":"267","author":"Kannel","year":"1992","journal-title":"JAMA"},{"key":"10.4065\/81.2.159_bib27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/01.STR.0000124122.71702.64","article-title":"Leukocyte count as an independent predictor of recurrent ischemic events","volume":"35","author":"Grau","year":"2004","journal-title":"Stroke"},{"key":"10.4065\/81.2.159_bib28","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.amjmed.2005.03.010","article-title":"White blood cell count and the incidence of ischemic stroke in coronary heart disease patients","volume":"118","author":"Koren-Morag","year":"2005","journal-title":"Am J Med"},{"key":"10.4065\/81.2.159_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archinte.165.5.500","article-title":"Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study","volume":"165","author":"Margolis","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.4065\/81.2.159_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002770050007","article-title":"Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment","volume":"79","author":"Andersson","year":"2000","journal-title":"Ann Hematol"},{"key":"10.4065\/81.2.159_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0369-8114(00)00024-9","article-title":"Efficacy and safety of hydroxyurea in patients with essential thrombocythemia","volume":"49","author":"Finazzi","year":"2001","journal-title":"Pathol Biol (Paris)"},{"key":"10.4065\/81.2.159_bib32","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood-2004-09-3426","article-title":"Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study","volume":"105","author":"Finazzi","year":"2005","journal-title":"Blood"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611616649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611616649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T21:20:36Z","timestamp":1589491236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611616649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0025619611616649"],"URL":"https:\/\/doi.org\/10.4065\/81.2.159","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}